Target intelligence / Profile preview

DosR-DosS-DosT two-component regulatory system (DosRST)

Target
DosRST
Molecular classification
Two-component regulatory system, Transcription factor, Histidine kinase, Heme-binding protein
01

Overview

The DosRST system is a critical two-component regulatory pathway in Mycobacterium tuberculosis (Mtb) that enables the bacterium to sense and adapt to host-induced environmental stresses such as hypoxia, nitric oxide (NO), and carbon monoxide (CO). It consists of two sensor histidine kinases, DosS and DosT, which detect these signals and a cognate response regulator, DosR, which orchestrates the expression of approximately 50 genes known as the dormancy regulon. This system is essential for Mtb to enter a state of non-replicating persistence (NRP), allowing it to survive for long periods within the host granuloma and develop high tolerance to standard antibiotics like isoniazid. Because NRP bacteria are a primary driver of the lengthy six-month tuberculosis treatment course, DosRST is a promising therapeutic target for adjunct therapies aimed at shortening treatment by eliminating the persistent bacterial reservoir. Experimental inhibitors have been identified that disrupt the pathway through various mechanisms, including targeting the sensor heme groups, inhibiting kinase autophosphorylation, or preventing DosR from binding to DNA.

Other names
DevR-DevS-DosT systemDosRS systemDormancy survival regulon systemDosR regulonTwo-component system DosRST
02

Mechanism of action

Inhibition of sensor kinase (DosS/DosT) autophosphorylation, oxidation or alkylation of the sensor kinase heme group, inhibition of phosphotransfer to DosR, and inhibition of DosR DNA binding.

03

Biological functions

Signal transductionAdaptation to hypoxiaMetabolic remodelingGene regulationInduction of dormancySensing of nitric oxide and carbon monoxidepH homeostasisTriacylglycerol synthesis regulation
04

Disease associations

Infection (Tuberculosis)Latent tuberculosisDrug-tolerant persistence
05

Safety considerations

Target specificity (avoiding cross-reactivity with human kinases)Drug delivery to hypoxic and necrotic granulomasPotential for antimicrobial resistance in malaria-endemic regions (for artemisinin-based inhibitors)Requirement for use as an adjunct therapy rather than a standalone antibiotic
06

Interacting drugs

Artemisinin

6 more in the full profile.

07

Biomarkers

hspX (heat shock protein X) expressiontgs1 (triacylglycerol synthase 1) expressionTriacylglycerol (TAG) accumulationDosR-regulated antigens (e.g., Rv2623, Rv3133c)

Beyond the preview

Go deeper on DosR-DosS-DosT two-component regulatory system (DosRST).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DosR-DosS-DosT two-component regulatory system (DosRST).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call